semaglutide cardiovascular trial news Diabetes Drug Could Help Reduce Risk for Events, Study Finds Long-Term SELECT Trial: Semaglutide Cuts

The mean Dental Anxiety Scale score was 11.4, and 39% (64 individuals) of participants reported high anxiety (DAS 13)

Verywell Health.(Accessed: 24 June 2025)

The set-point can vary widely across individuals

The $179 three-month plan does not cover the cost of medicine, and Sesame cautioned on its website that GLP-1s may cost anywhere from $950 to $1,600 a month without insurance

EBioMedicine 93:104642

About Sem-P (Semaglutide) Sem-P (Semaglutide) is GLP-1 receptor agonist used to Helps control blood sugar in Type 2 Diabetes Mellitus (with diet & exercise) Reduces risk of major cardiovascular events (heart attack, stroke, death) in high-risk patients Supports chronic weight management in: Obesity Overweight with comorbidities (e.g., hypertension, diabetes, dyslipidemia) Used in MASH (Metabolic Dysfunction-Associated Steatohepatitis)